Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Observe Medical with progress in Italy: Major tender win, exclusive distribution agreement and significant order

OBSRVRegulatory press release25.09.2025 klo 17.05
Oslo, 25 September 2025 - Observe Medical ASA (the "Company" or "Observe
Medical") announces further progress in the Italian market.

The Company's distributor in Italy has secured a public tender to supply
UnoMeterT products into the largest region in Italy, corresponding to an
estimated olume of approximately 240,000 units annually for a period of three
years.

Following extended cooperation, Observe Medical has also entered into a mutually
exclusive distribution agreement with the distributor for the UnoMeterT product
family in Italy. In addition, the Company has received a significant order
related to this agreement.

Jørgen Mann, CEO of Observe Medical, commented: "Italy has historically been one
of the markets where the UnoMeterT products have held the highest market shares
and by winning the largest region in Italy which represents more than 15% of the
market, on top of the already gained business, secures  a strong growth for
Observe Medical and a solid basis for further market share expansion".

Observe Medical reminds investors, analysts, and other stakeholders of the
Company's upcoming trading update on Tuesday 7 October 2025, at 09:00 CET, which
will be held virtually and streamed via webcast at the following
link:  https://channel.royalcast.com/landingpage/hegnarmedia/20251007_1/ (https:
/
/eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fchannel.royalcast.com
%
2Flandingpage%2Fhegnarmedia%2F20251007_1%2F&data=05%7C02%7Cjohan.fagerli%40obser
v
emedical.com%7Ce9b067cb4eae445bddd108ddf67e93ae%7C139dbc03ecf246efb467a338c990a8
d
6%7C0%7C0%7C638937745682186722%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsI
l
YiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&
s
data=v%2BxiEF3WLlkQUQ8LiZLpGaqwOEgGImgwVwBOYtfEaDg%3D&reserved=0)

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available atwww.observemedical.com.